Trilliome develops precision bioactives that reprogram the gut microbiome to enhance resilience, cognition, and healthy aging. Unlike fiber or generic probiotics, our patented small molecules activate native “neuro-specialist” microbes, boosting brain and immune metabolites, reducing inflammation. Powered by an AI-driven discovery engine and sustainable plant sources, we deliver clinically validated, science-backed ingredients to a $25B gut-brain health market, followed by metabolic and women's health. Trilliome is building the category-defining platform for gut-driven longevity.
31.10.2025
More than 20 Swiss biotech companies to exhibit at Bio Europe (startupticker.ch)
27.10.2025
Zurich-based Trilliome awarded €50’000 (startupticker.ch)
02.05.2025
Extra boost for water, food and construction solutions (startupticker.ch)
No milestones
No Jobs
No videos and documents
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
Website:
www.trilliome.com
Headquarter:
Zürich
Foundation Date:
March 2023
Technology:
Sectors: